Two 29-residue peptides were prepared, one of which (ChPepz) was designed by surface-simulation synthesis to mimic the active site of a-chymotrypsin, and the other (TrPepz), which contained four substitutions relative to ChPepz, was fashioned after the active site of trypsin. Each peptide was cyclized by a disulfide bond. The ChPepz monomer effected hydrolysis of the ester group in N-benzoyl-L-tyrosine ethyl ester, an a-chymotrypsin substrate, with Km and kt values that were comparable to those of a-chymotrypsin. ChPepz was completely inactivated by diisopropyl fluorophosphate (DIFP), L-1-p-tosylamino-2-phenylethyl chloromethyl ketone (TPCK), or reduction of the disulfide bond. It had no catalytic activity on N-tosyl-L-arginine methyl ester, a trypsin substrate. On the other hand, TrPepz, which had no effect on N-benzoyl-L-tyrosine ethyl ester, hydrolyzed N-tosyl-L-arginine methyl ester with a Km value that was essentially identical to that of trypsin, but its k5,,, value was almost half that of trypsin. TrPepz was fully inactivated by reduction of the disulfide bond, by DIFP, or by phenylmethylsulfonyl fluoride but not by TPCK. It was also completely inhibited by soybean trypsin inhibitor, bovine pancreatic trypsin inhibitor, and human a1-antitrypsin. ChPepz and TrPepz hydrolyzed proteins (myoglobin and casein) to give panels ofpeptides that were similar to those of the same protein obtained with the respective enzyme. However, TrPepz was more efficient than trypsin at hydrolyzing the C bonds of two or more consecutive lysine and/or arginine residues. Like its esterase activity, the proteolytic activity of ChPepz was inhibited by either DIFP or TPCK whereas that of TrPepz was inhibited by either DIFP or phenylmethylsulfonyl fluoride but not by TPCK. Finally, ChPepz and TrPepz were each more active at low temperature than the respective enzyme. This ability to construct fully functional peptide enzymes (pepzymes) of chosen specificities should find many practical applications.
N-benzoyl-L-tyrosine ethyl ester, hydrolyzed N-tosyl-L-arginine methyl ester with a Km value that was essentially identical to that of trypsin, but its k5,,, value was almost half that of trypsin. TrPepz was fully inactivated by reduction of the disulfide bond, by DIFP, or by phenylmethylsulfonyl fluoride but not by TPCK. It was also completely inhibited by soybean trypsin inhibitor, bovine pancreatic trypsin inhibitor, and human a1-antitrypsin. ChPepz and TrPepz hydrolyzed proteins (myoglobin and casein) to give panels ofpeptides that were similar to those of the same protein obtained with the respective enzyme. However, TrPepz was more efficient than trypsin at hydrolyzing the C bonds of two or more consecutive lysine and/or arginine residues. Like its esterase activity, the proteolytic activity of ChPepz was inhibited by either DIFP or TPCK whereas that of TrPepz was inhibited by either DIFP or phenylmethylsulfonyl fluoride but not by TPCK. Finally, ChPepz and TrPepz were each more active at low temperature than the respective enzyme. This ability to construct fully functional peptide enzymes (pepzymes) of chosen specificities should find many practical applications.
The critical role of enzymes in the catalysis of biological processes has, for decades, made enzymes the subject of the most intense studies. The duplication of the activities of enzymes by synthetic analogs has been a prime goal of biochemists. X-ray crystallography of enzymes and their complexes with substrate analogs or inhibitors has provided detailed information about the architecture and contact residues ofthe active sites of many enzymes. In 1976, Atassi and coworkers (1, 2) devised the technique of "surfacesimulation" synthesis, in which the spatially adjacent residues constituting a protein binding site are directly linked via peptide bonds with appropriate spacing and directionality. A peptide is thus generated that does not exist in the protein but mimics the conformation and disposition of the residues of the binding site. Surface-simulation synthesis (for review, see ref. 3 ) has been employed to mimic protein antigenic sites (1, The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
2, 4-8), the combining sites of antibodies (9) (10) (11) , and the substrate-binding site of trypsin (12) . Although the peptide that mimicked the latter substrate-binding site displayed all the expected binding activities of trypsin with substrate analogs and inhibitors, it had no enzymatic activity. After several revisions of surface-simulation synthesis, we have now produced a number of catalytically efficient peptide enzymes (named herein pepzymes) that exhibit the enzymatic activity and specificity of the correlate enzyme. This paper reports our studies with two pepzymes that possess the activities and specificities of a-chymotrypsin (aCT) and trypsin.
MATERIALS AND METHODS Materials. Myoglobin (Mb) was the major chromatographic component from crystallized sperm-whale Mb as described (13) . Sources of other reagents were as follows: N-benzoyl-L-tyrosine ethyl ester (BTEE) and N-tosyl-L-arginine methyl ester (TAME) (Aldrich); aCT, L-1-p-tosylamino-2-phenylethyl chloromethyl ketone (TPCK)-trypsin, bovine pancreatic trypsin inhibitor, and soybean trypsin inhibitor (Worthington); bovine milk ,Bcasein [which contained "10% (wt/vol) a-casein], diisopropyl fluorophosphate (DIFP), phenylmethylsulfonyl fluoride (PMSF), and human a1-antitrypsin (Sigma); peptide synthesis reagents and N"-fluoren-9-ylmethoxycarbonyl amino acid derivatives (Vega Biotechnologies).
Peptide Synthesis. The rationale for the design of the peptides and their structures is given in the Discussion. The peptides were prepared on a Coupler 2200 peptide synthesizer (Vega Biotechnologies), starting with a benzyloxybenzyl alcohol resin to which 9-fluorenylmethylcarbonyl-S-tertbutyl cysteine had been coupled. The methods for synthesis and cleavage from the resin have been described elsewhere in detail (14) .* Cyclization of the Peptide and Purification of the Monomer. A portion (50 mg) of the synthetic product was dissolved in 2 ml of 8.0 M urea containing 5% (vol/vol) 2-mercaptoethanol, preadjusted to pH 8.5 with triethylamine. The solution was stirred gently on a magnetic stirrer for 3 hr at room temperature, after which it was applied on a column (90 x 1.6 cm) of Sephadex G-15 and eluted with 0.025 M acetic acid to remove the urea and mercaptoethanol. The fractions containing the peptide were pooled and diluted with 3 liters of 0.025 M acetic acid and the pH was adjusted to 8.0 on the pH meter by the addition of triethylamine. The solution was Abbreviations: BTEE, N-benzoyl-L-tyrosine ethyl ester; aCT, achymotrypsin; ChPepz, peptide designed to mimic the active site of a-CT; DIFP, diisopropyl fluorophosphate; PMSF, phenylmethylsulfonyl fluoride; TAME, N-tosyl-L-arginine methyl ester; TPCK, L-1-p-tosylamino-2-phenylethyl chloromethyl ketone; TrPepz, peptide designed to mimic the active site of trypsin; Mb, myoglobin. *The precise methods used for synthesizing the peptides and other experimental details will be provided by the authors upon request.
Proc. Natl. Acad. Sci (15) , using 7.26 x 10-4 mol of aCT or 4.49 x 10-4 mol of ChPepz and various substrate concentrations (from 3 to 6 mM) in a total reaction volume of 1.0 ml. The change of A256 was monitored on a recording spectrophotometer against a reference cuvette containing 1 ml of the same concentration of BTEE, but without aCT or ChPepz. Controls included trypsin, TrPepz (which are inactive against BTEE), and several linear and cyclic peptides from our own peptide library.
(ii) Tryptic activity. This was measured at 25°C in 0.046 M Tris HCl (pH 8.0), containing 0.0115 M CaCl2 (15) using 8.4 X 10-4 ,umol of trypsin or 1.66 x 1o-3 ,umol of TrPepz, which were allowed to hydrolyze various concentrations of TAME in a reaction volume of 1.0 ml. Hydrolysis was monitored on a recording spectrophotometer by change in A247 against a reference cuvette containing the same concentration of TAME, but without trypsin or TrPepz. aCT and ChPepz (which do not hydrolyze TAME) and several linear and cyclic peptides from our own library were used as controls.
(iii) Temperature effects. Measurements were also carried out at different temperatures (from 10°C to 48°C) as described above.
Kinetic constants for hydrolysis of BTEE and TAME were determined from the linear plots of 1/initial velocity (Vi in ,umol/min) versus 1/substrate concentration as described (16) .
Inhibition of Enzymatic Activity. The effects ofinhibitors or disulfide bond reduction on activities were determined as described above except that the enzyme (aCT, 6 .04 x 10o-,umol; trypsin, 2.1 x 10-5 ,mol) or pepzyme (ChPepz, 7 spectrophotometric scans of these reactions at 256 nm traced on the zero-hydrolysis baseline). ChPepz did not hydrolyze TAME (which is a trypsin substrate) and, as mentioned below, BTEE was not hydrolyzed by TrPepz or by control cyclic and linear peptides that are not related to aCT. At 10°C, ChPepz was more active than aCT (percent activity relative to that of aCT at 35°C: aCT, 6.8%; ChPepz, 12.6%). At 48°C (where aCT was totally inactive) ChPepz continued to exhibit some catalytic activity (-3.5% relative to the aCT activity at 35°C).
Activity of TrPepz on Ester Substrates. The activity of TrPepz on TAME was very much like that of trypsin. Lineweaver-Burk plots (Fig. lb) of reactions at different TAME concentrations showed that the affinity of TrPepz for the substrate (Km) was similar to that of trypsin. It hydrolyzed TAME at a rate that was -409o relative to that obtained with the enzyme itself ( Table 1 ). The activity of TrPepz on TAME was not affected by TPCK, but it was completely lost by reduction ofthe disulfide bond or by premixing with DIFP, PMSF, soybean trypsin inhibitor, bovine pancreatic trypsin inhibitor, and human a1-antitrypsin (these reactions traced on the zero-hydrolysis baseline in the spectrophotometric scans at 247 nm). TrPepz had no effect on BTEE and, as mentioned above, TAME was not hydrolyzed by ChPepz or by control unrelated (to trypsin) cyclic or linear peptides. TrPepz was more active than trypsin at 10°C (percent activity relative to that of trypsin at 35°C; trypsin, 4.5%; TrPepz, 7.4%). In the range 18°C-48°C, the activity of TrPepz was about half that of trypsin.
Proteolytic Activity of ChPepz. The action of ChPepz on Mb and casein resulted in the hydrolysis of each protein into peptides whose fingerprints were identical to those obtained by aCT hydrolysis of the respective protein (Fig. 2) . The ChPepz hydrolysis of proteins was quite efficient, being achieved in a time frame that was enzyme-like, and this activity was completely inhibited by TPCK (Fig. 3) . However, TrPepz was in fact more efficient at hydrolyzing Lys-Lys, Lys-Lys-Lys, Arg-Lys, and Lys-Arg bonds as evident from the apparent higher yields of lysine and arginine in hydrolyses by TrPepz, as compared to those by trypsin. Finally, the proteolytic action ofTrPepz, like that of trypsin, was completely inhibited by either DIFP or PMSF whereas TPCK had no effect. 
DISCUSSION
For almost a century, enzymes have occupied center stage in biochemistry and biology. After developing a method for peptide synthesis in 1907, Emil Fisher hoped to synthesize the first "artificial ferment" (enzyme) (18) . Subsequently, major advances in the knowledge of protein structure and in solid-phase peptide chemistry and automation have enabled the synthesis of whole enzymes (19) (20) (21) (22) . These enzymes, however, were relatively small proteins (e.g., ribonuclease and human immunodeficiency virus protease) and their yields were extremely low, due to the inherent limitations of solidphase peptide synthesis. But, clearly, to make a whole protein is not a viable approach for the construction of small enzymes in practical amounts and is not at all useful for larger enzymes. Quite recently, a construct was reported that consisted of four helical peptides in a bundle that contained at its amino end serine, histidine, and aspartic acid in a spatial arrangement similar to that in chymotrypsin (23 (1993) 8285 lyzed acetyltyrosine ethyl ester for -100 turnovers, but at a rate of catalysis that was only 0.02% that of aCT. Also, monoclonal antibodies with catalytic activity have been prepared by using transition-state intermediates of the substrate as the immunizing antigen (24) (25) (26) (27) (28) . These contributions may potentially have important applications but, realistically to date, no protein or peptide designed de novo has functioned like a true enzyme (e.g., hydrolyzing protein substrate in a specific manner at preselected peptide bonds and with a useful rate of catalysis).
As stated in the Introduction, a surface-simulation synthetic peptide was constructed (12) that possessed the expected binding activities of trypsin with substrates and inhibitors but had no significant catalytic activity. Nevertheless, the ability to produce substrate binding encouraged us to improve the designs to achieve an enzymically active peptide. We made 10 design changes. The following cyclic peptide designs were active (shown here for the trypsin active site): design 1, dDSGGVSWGGLGDGAAHGGFHYC; design 2, DSG_QDSGGVSWGGLGDGAAHGGFHYC; design 3, CFGGSDGOGSDGGVSWGLGGDGAAHC (active site residues are underlined; others are spacers). Under the conditions described above, the rate of hydrolysis of TAME by the final TrPepz design (Fig. 4) was better than designs [1] [2] [3] by 250, 123, and 72 times, respectively. The peptide maps of 144-hr Mb or casein hydrolysates by designs 2 and 3 coma 10.27 13.16 -!,~19
8. 29   FIG. 4 . Design of the surface-simulation synthetic peptides mimicking the active sites of aCT (ChPepz) and trypsin (TrPepz). (a) Contact residues of the active site (shaded areas) and the Ca-to-Ca distances (in A) separating the appropriate residues. Residue numbers are based on bovine chymotrypsinogen sequence. (b) Surfacesimulation synthetic peptides designed to mimic the active sites. The residues in the shaded areas are the active site residues of bovine aCT and those linking these shaded areas are glycine spacers used to achieve appropriate distances of separation between the respective residues and regions of the site. Cter is the C-terminal cysteine and Nter denotes the N-terminal cysteine of the peptides that are cyclized by the disulfide between the two cysteine residues. The outer sequence (which differs from ChPepz in four positions only:
Phe-39 -) Tyr, Ile-99 --Leu, Ser-189 -> Asp, Gln) represents the structure of TrPepz, which mimics the active sites of trypsin. pared well to the respective tryptic hydrolysates. The cyclic structures of designs 1-3 were essential for activity. Similar results were obtained with the corresponding analogs of the aCT active site.
The essential residues ofthe active sites of aCT and trypsin are shown in Fig. 4a , together with their position in the sequence (using bovine chymotrypsinogen sequence numbers) and the distances (in A) separating them. These have been implicated as essential active site residues by chemical and crystallographic evidence, which has been reviewed (12) . The sequence of aCT was obtained from ref. 29 and the x-ray coordinates are known to 1.68-A resolution (30) . The bovine trypsin sequence and x-ray coordinates were from refs. 31 and 32, respectively. To determine the appropriate lengths of spacers to be used for linking the active site residues, we calculated the average (of 15) Ca-to-Ca distances in single peptide bonds and two and three consecutive peptide bonds. These distances were as follows: one peptide bond (Ca-toCa), 3 .80 ± 0.20 A; two peptide bonds (distance between C1
and CO' in Ca-C2a-Co,, 6 .20 ± 1.00 A; three peptide bonds (distance between Cf and Ca in C1-C2'-C'-C ), 7.94 ± 2.07 A. Therefore, the distances separating the contact residues (Fig.  4a ) could be well accommodated by the glycine spacers shown in Fig. 4b . Glycine was found (3) to be most suited for use in spacers, probably because ofits flexibility and absence of interfering side chains. The cyclic design, which is crucial for activity, requires closure. We measured several disulfide bonds in proteins and found that the Ca-to-Ca distance in Cys-S-S-Cys is 5.5 ± 0.4 A (range, 5.11-5.93 (34) and 187 sec-1 (35) , respectively, at pH 8.0 and 25°C. The activity of TrPepz was completely inhibited by DIFP, PMSF, bovine pancreatic trypsin inhibitor, soybean trypsin inhibitor, and human alantitrypsin, all known to be inhibitors of trypsin. Like ChPepz, the cyclic structure of TrPepz was essential for activity. The most striking finding was the exquisite specificity of TrPepz for cleavage of the C-peptide bonds of arginine and lysine residues in peptides and proteins. Its action on Mb or casein yielded peptide fragments that were similar to those obtained by hydrolysis with trypsin itself. In fact, TrPepz appeared to be more efficient than trypsin at hydrolyzing Lys-Lys, Lys-Arg, Arg-Lys, and Lys-Lys-Lys bonds. Thus, the substitution of four residues in the ChPepz design caused an unequivocal functional conversion from a chymotryptic to a tryptic activity.
The lower rate of catalysis by ChPepz and TrPepz (relative to their respective enzyme) is probably caused by the flexibility of the peptide as it searches, through an equilibrium of conformational states and induced fit, for a catalytically productive conformation. Also, the reverse sequence of residues 189-195 may have caused reduction of the rate of catalysis, although an analog with D-amino acids in this segment showed similar kinetics. The virtual loss of catalytic activity when the peptides are rendered acyclic is most probably due to the inability of the open-chain structure to achieve such a conformation. This would explain why the first-generation open-chain peptide (12) 
